5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.58%
Revenue growth 1.25-1.5x HUH1V.HE's 9.38%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
-2.59%
Negative gross profit growth while HUH1V.HE is at 9.32%. Joel Greenblatt would examine cost competitiveness or demand decline.
26.46%
EBIT growth above 1.5x HUH1V.HE's 4.75%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
26.46%
Operating income growth above 1.5x HUH1V.HE's 4.75%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
29.09%
Net income growth above 1.5x HUH1V.HE's 10.00%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
-25.81%
Negative EPS growth while HUH1V.HE is at 11.11%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.81%
Negative diluted EPS growth while HUH1V.HE is at 11.11%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.69%
Share reduction while HUH1V.HE is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.69%
Reduced diluted shares while HUH1V.HE is at 0.01%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
697.62%
OCF growth above 1.5x HUH1V.HE's 101.49%. David Dodd would confirm a clear edge in underlying cash generation.
524.12%
FCF growth above 1.5x HUH1V.HE's 302.74%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-17.22%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 61.31%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
43.94%
5Y revenue/share CAGR above 1.5x HUH1V.HE's 17.56%. David Dodd would look for consistent product or market expansions fueling outperformance.
5.72%
3Y revenue/share CAGR under 50% of HUH1V.HE's 11.47%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
674.87%
10Y OCF/share CAGR above 1.5x HUH1V.HE's 147.95%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
761.09%
5Y OCF/share CAGR above 1.5x HUH1V.HE's 86.08%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
264.22%
Positive 3Y OCF/share CAGR while HUH1V.HE is negative. John Neff might see a big short-term edge in operational efficiency.
235.29%
Net income/share CAGR above 1.5x HUH1V.HE's 60.39% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
283.33%
Positive 5Y CAGR while HUH1V.HE is negative. John Neff might view this as a strong mid-term relative advantage.
91.67%
Positive short-term CAGR while HUH1V.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
59.17%
10Y equity/share CAGR in line with HUH1V.HE's 61.57%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
69.86%
5Y equity/share CAGR above 1.5x HUH1V.HE's 29.30%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
29.41%
3Y equity/share CAGR above 1.5x HUH1V.HE's 12.96%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
67.55%
Stable or rising mid-term dividends while HUH1V.HE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
22.04%
Our short-term dividend growth is positive while HUH1V.HE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
8.76%
AR growth well above HUH1V.HE's 3.88%. Michael Burry fears inflated revenue or higher default risk in the near future.
-5.91%
Inventory is declining while HUH1V.HE stands at 2.77%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.40%
Asset growth above 1.5x HUH1V.HE's 0.77%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.30%
Positive BV/share change while HUH1V.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-2.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-8.39%
We cut SG&A while HUH1V.HE invests at 16.30%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.